Flat panel list prices fall

Article

Planar Systems cut list prices last month for its medical-grade flat-panel monitors by almost half, framing the move as part of an effort to make flat-panel display systems more affordable. The company's most popular product, a 3-megapixel dual-display

Planar Systems cut list prices last month for its medical-grade flat-panel monitors by almost half, framing the move as part of an effort to make flat-panel display systems more affordable. The company's most popular product, a 3-megapixel dual-display monitor, which was listed for $28,000 now lists for $15,000. Planar has maintained margins on its products by taking costs out of their manufacture. This was achieved by redesigning boards and outsourcing manufacturing to Asia, according to the company.

Planar executives said the price cuts should allow a wider range of healthcare facilities to deploy Planar displays. They noted, however, that the new prices on Planar's 2-, 3-, and 5- megapixel monitors bring the company more in line with competitors whose products deliver similar image quality.

Planar's decision to reduce list prices marked an evolutionary step in the sales history of flat-panel monitors: the transition from an early-adopter market to one of mass sales, according to Quest International, which distributes flat-panel medical monitors made by Totoku of Japan. Sales will increasingly be decided by software and support services, Planar and Quest executives agreed.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.